Jake Bauer - 18 Apr 2025 Form 3 Insider Report for Immunovant, Inc. (IMVT)

Role
Director
Signature
/s/ Christopher Van Tuyl, Attorney-in-Fact
Issuer symbol
IMVT
Transactions as of
18 Apr 2025
Net transactions value
$0
Form type
3
Filing time
28 Apr 2025, 17:02:21 UTC
Previous filing
10 Feb 2025
Next filing
05 May 2025

No securities are beneficially owned.